is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in

Higashinari-ku, Osaka is one of 24 wards of Osaka, Japan. History * April 1, 1925: The area that became Higashinari-ku was incorporated into Osaka as part of the second major expansion of the city. The ward was created from the former district of Higashinari-gun, but ...

, and

Fujinomiya, Shizuoka is a city located in central Shizuoka Prefecture, Japan. , the city had an estimated population of 132,507 in 56,655 households, and a population density of 340 persons per km². The total area of the city is . History The city name comes from ...

., and its central research institute at Minase, Shimamoto-cho,

Mishima District, Osaka is a district located in Osaka Prefecture, Japan. As of 2009, the district has an estimated population of 29,003 and a density Density (volumetric mass density or specific mass) is the substance's mass per unit of volume. The symbol most o ...

.Ono Pharmaceutical - Research & Development
/ref> Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono () started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. () in 1948. Ono has been listed in

Tokyo Stock Exchange The , abbreviated as Tosho () or TSE/TYO, is a stock exchange located in Tokyo, Japan. It is the third largest stock exchange in the world by aggregate market capitalization of its listed companies, and the largest in Asia. It had 2,292 listed ...

since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen.

Nivolumab Nivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer. This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urotheli ...

, the cancer drug based on the research of Prof.Dr.

Tasuku Honjo is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). He is also known for his molecular identification o ...

of Kyoto University, who received the

Nobel Prize The Nobel Prizes ( ; sv, Nobelpriset ; no, Nobelprisen ) are five separate prizes that, according to Alfred Nobel's will of 1895, are awarded to "those who, during the preceding year, have conferred the greatest benefit to humankind." Alfr ...

later in 2018, is marketed by both Ono Pharmaceutical and

Bristol-Myers Squibb The Bristol Myers Squibb Company (BMS) is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the ''Fortune'' 500 list of the lar ...

References

External links

Official site
{{Authority control Pharmaceutical companies of Japan Health care companies of Japan Biotechnology companies of Japan Companies listed on the Tokyo Stock Exchange Companies based in Osaka Pharmaceutical companies established in 1717 1717 establishments in Japan Japanese brands Mitsubishi

See also

References

External links